Functional Assays for Measuring the Catalytic Activity of Ribosome Inactivating Proteins
Abstract
:1. Introduction
2. Depurination Assays
2.1. Aniline Cleavage Assay
2.2. Primer Extension Assay
2.3. qRT-PCR Assay
2.4. Adenine Detection Assay Using HPLC
2.5. Enzymatically-Coupled Adenine Detection Assays
3. Translation Inhibition Assays
3.1. In Vitro Translation Inhibition Assays
3.2. Mammalian Cell-Based Assays
3.2.1. In-Cell Radioactive Amino Acid Incorporation Assay
3.2.2. In-Cell Luciferase Synthesis Assay
3.2.3. Cell Based Luciferase Assay
3.2.4. In-Cell GFP Synthesis Assay
4. Advantages and Disadvantages of the Different Assays to Measure the Activity of RIPs
5. Contributions of the Different Assays to Measure Activity to RIP Research
Author Contributions
Acknowledgments
Conflicts of Interest
References
- Stirpe, F. Ribosome-inactivating proteins: From toxins to useful proteins. Toxicon 2013, 67, 12–16. [Google Scholar] [CrossRef] [PubMed]
- Lapadula, W.J.; Ayub, M.J. Ribosome inactivating proteins from an evolutionary perspective. Toxicon 2017, 136, 6–14. [Google Scholar] [CrossRef] [PubMed]
- Walsh, M.J.; Dodd, J.E.; Hautbergue, G.M. Ribosome-inactivating proteins: Potent poisons and molecular tools. Virulence 2013, 4, 774–784. [Google Scholar] [CrossRef] [PubMed]
- Bergan, J.; Dyve Lingelem, A.B.; Simm, R.; Skotland, T.; Sandvig, K. Shiga toxins. Toxicon 2012, 60, 1085–1107. [Google Scholar] [CrossRef] [PubMed]
- Audi, J.; Belson, M.; Patel, M.; Schier, J.; Osterloh, J. Ricin poisoning: A comprehensive review. JAMA 2005, 294, 2342–2351. [Google Scholar] [CrossRef] [PubMed]
- Siegler, R.; Oakes, R. Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr. Opin. Pediatr. 2005, 17, 200–204. [Google Scholar] [CrossRef] [PubMed]
- Nielsen, K.; Boston, R.S. Ribosome-inactivating proteins: A plant perspective. Annu. Rev. Plant Physiol. Plant Mol. Biol. 2001, 52, 785–816. [Google Scholar] [CrossRef] [PubMed]
- Spooner, R.A.; Lord, J.M. How ricin and Shiga toxin reach the cytosol of target cells: Retrotranslocation from the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 2012, 357, 19–40. [Google Scholar] [PubMed]
- Endo, Y.; Tsurugi, K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 1987, 262, 8128–8130. [Google Scholar] [PubMed]
- Diaconu, M.; Kothe, U.; Schlunzen, F.; Fischer, N.; Harms, J.M.; Tonevitsky, A.G.; Stark, H.; Rodnina, M.V.; Wahl, M.C. Structural basis for the function of the ribosomal L7/L2 stalk in factor binding and GTPase activation. Cell 2005, 121, 991–1004. [Google Scholar] [CrossRef] [PubMed]
- Endo, Y.; Tsurugi, K.; Yutsudo, T.; Takeda, Y.; Ogasawara, T.; Igarashi, K. Site of action of a Vero toxin (Vt2) from Escherichia coli O157:H7and of Shiga toxin on eukaryotic ribosomes. Eur. J. Biochem. 1988, 171, 45–50. [Google Scholar] [CrossRef] [PubMed]
- Endo, Y.; Tsurugi, K.; Lambert, J.M. The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: The RNA N-glycosidase activity of the proteins. Biochem. Biophys. Res. Commun. 1988, 150, 1032–1036. [Google Scholar] [CrossRef]
- Zhang, J.S.; Liu, W.Y. The mechanism of action of trichosanthin on eukaryotic ribosomes-RNA N-glycosidase activity of the cytotoxin. Nucleic Acids Res. 1992, 20, 1271–1275. [Google Scholar] [CrossRef] [PubMed]
- Zhabokritsky, A.; Kutky, M.; Burns, L.A.; Karran, R.A.; Hudak, K.A. RNA toxins: Mediators of stress adaptation and pathogen defense. Wiley Interdiscip. Rev. RNA 2011, 2, 890–903. [Google Scholar] [CrossRef] [PubMed]
- Olombrada, M.; Lazaro-Gorines, R.; Lopez-Rodriguez, J.C.; Martinez-Del-Pozo, A.; Onaderra, M.; Maestro-Lopez, M.; Lacadena, J.; Gavilanes, J.G.; Garcia-Ortega, L. Fungal ribotoxins: A review of potential biotechnological applications. Toxins 2017, 9, 71. [Google Scholar] [CrossRef] [PubMed]
- Endo, Y.; Tsurugi, K. The RNA N-glycosidase activity of ricin A-chain. Nucleic Acids Symp. Ser. 1988, 19, 139–142. [Google Scholar]
- Hartley, M.R.; Legname, G.; Osborn, R.; Chen, Z.; Lord, J.M. Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett. 1991, 290, 65–68. [Google Scholar] [CrossRef]
- Hudak, K.A.; Wang, P.; Tumer, N.E. A novel mechanism for inhibition of translation by pokeweed antiviral protein: Depurination of the capped RNA template. RNA 2000, 6, 369–380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tumer, N.E.; Li, X.P. Interaction of ricin and Shiga toxins with ribosomes. Curr. Top. Microbiol. Immunol. 2012, 357, 1–18. [Google Scholar] [PubMed]
- Chiou, J.C.; Li, X.P.; Remacha, M.; Ballesta, J.P.; Tumer, N.E. The ribosomal stalk is required for ribosome binding, depurination of the rRNA and cytotoxicity of ricin A chain in Saccharomyces cerevisiae. Mol. Microbiol. 2008, 70, 1441–1452. [Google Scholar] [CrossRef] [PubMed]
- McCluskey, A.J.; Poon, G.M.; Bolewska-Pedyczak, E.; Srikumar, T.; Jeram, S.M.; Raught, B.; Gariepy, J. The catalytic subunit of Shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain. J. Mol. Biol. 2008, 378, 375–386. [Google Scholar] [CrossRef] [PubMed]
- Chiou, J.C.; Li, X.P.; Remacha, M.; Ballesta, J.P.; Tumer, N.E. Shiga toxin 1 is more dependent on the P proteins of the ribosomal stalk for depurination activity than Shiga toxin 2. Int. J. Biochem. Cell Biol. 2011, 43, 1792–1801. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Too, P.H.; Ma, M.K.; Mak, A.N.; Wong, Y.T.; Tung, C.K.; Zhu, G.; Au, S.W.; Wong, K.B.; Shaw, P.C. The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome. Nucleic Acids Res. 2009, 37, 602–610. [Google Scholar] [CrossRef] [PubMed]
- Hudak, K.A.; Dinman, J.D.; Tumer, N.E. Pokeweed antiviral protein accesses ribosomes by binding to L3. J. Biol. Chem. 1999, 274, 3859–3864. [Google Scholar] [CrossRef] [PubMed]
- Rajamohan, F.; Ozer, Z.; Mao, C.; Uckun, F.M. Active center cleft residues of pokeweed antiviral protein mediate its high-affinity binding to the ribosomal protein L3. Biochemistry 2001, 40, 9104–9114. [Google Scholar] [CrossRef] [PubMed]
- Chan, D.S.; Chu, L.O.; Lee, K.M.; Too, P.H.; Ma, K.W.; Sze, K.H.; Zhu, G.; Shaw, P.C.; Wong, K.B. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses. Nucleic Acids Res. 2007, 35, 1660–1672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shi, W.W.; Tang, Y.S.; Sze, S.Y.; Zhu, Z.N.; Wong, K.B.; Shaw, P.C. Crystal structure of ribosome-inactivating protein ricin A chain in complex with the C-terminal peptide of the ribosomal stalk protein P2. Toxins 2016, 8, 296. [Google Scholar] [CrossRef] [PubMed]
- Fan, X.; Zhu, Y.; Wang, C.; Niu, L.; Teng, M.; Li, X. Structural insights into the interaction of the ribosomal P stalk protein P2 with a type II ribosome-inactivating protein ricin. Sci. Rep. 2016, 6, 37803. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bozza, W.P.; Tolleson, W.H.; Rivera Rosado, L.A.; Zhang, B. Ricin detection: Tracking active toxin. Biotechnol. Adv. 2015, 33, 117–123. [Google Scholar] [CrossRef] [PubMed]
- Duracova, M.; Klimentova, J.; Fucikova, A.; Dresler, J. Proteomic methods of detection and quantification of protein toxins. Toxins 2018, 10, 99. [Google Scholar] [CrossRef] [PubMed]
- Basu, D.; Li, X.P.; Kahn, J.N.; May, K.L.; Kahn, P.C.; Tumer, N.E. The A1 subunit of Shiga toxin 2 has higher affinity for ribosomes and higher catalytic activity than the A1 subunit of Shiga toxin 1. Infect. Immun. 2015, 84, 149–161. [Google Scholar] [CrossRef] [PubMed]
- May, K.L.; Li, X.P.; Martinez-Azorin, F.; Ballesta, J.P.; Grela, P.; Tchorzewski, M.; Tumer, N.E. The P1/P2 proteins of the human ribosomal stalk are required for ribosome binding and depurination by ricin in human cells. FEBS J. 2012, 279, 3925–3936. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, X.P.; Chiou, J.C.; Remacha, M.; Ballesta, J.P.; Tumer, N.E. A two-step binding model proposed for the electrostatic interactions of ricin A chain with ribosomes. Biochemistry 2009, 48, 3853–3863. [Google Scholar] [CrossRef] [PubMed]
- Li, X.P.; Kahn, P.C.; Kahn, J.N.; Grela, P.; Tumer, N.E. Arginine residues on the opposite side of the active site stimulate the catalysis of ribosome depurination by ricin A chain by interacting with the P-protein stalk. J. Biol. Chem. 2013, 288, 30270–30284. [Google Scholar] [CrossRef] [PubMed]
- Li, X.P.; Tumer, N.E. Differences in ribosome binding and sarcin/ricin loop depurination by Shiga and ricin holotoxins. Toxins 2017, 9, 133. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.; Li, X.P.; Chen, B.Y.; Tumer, N.E. Ricin uses arginine 235 as an anchor residue to bind to P-proteins of the ribosomal stalk. Sci. Rep. 2017, 7, 42912. [Google Scholar] [CrossRef] [PubMed]
- Basu, D.; Kahn, J.N.; Li, X.P.; Tumer, N.E. Conserved arginines at the P-protein stalk binding site and the active site are critical for ribosome interactions of Shiga toxins but do not contribute to differences in the affinity of the A1 subunits for the ribosome. Infect. Immun. 2016, 84, 3290–3301. [Google Scholar] [CrossRef] [PubMed]
- Iordanov, M.S.; Pribnow, D.; Magun, J.L.; Dinh, T.H.; Pearson, J.A.; Chen, S.L.; Magun, B.E. Ribotoxic stress response: Activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28s rRNA. Mol. Cell. Biol. 1997, 17, 3373–3381. [Google Scholar] [CrossRef] [PubMed]
- Jetzt, A.E.; Cheng, J.S.; Li, X.P.; Tumer, N.E.; Cohick, W.S. A relatively low level of ribosome depurination by mutant forms of ricin toxin A chain can trigger protein synthesis inhibition, cell signaling and apoptosis in mammalian cells. Int. J. Biochem. Cell Biol. 2012, 44, 2204–2211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jetzt, A.E.; Li, X.P.; Tumer, N.E.; Cohick, W.S. Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome. Toxicol. Appl. Pharmacol. 2016, 310, 120–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, K.-M.; Yusa, K.; Chu, L.-O.; Yu, C.W.-H.; Oono, M.; Miyoshi, T.; Ito, K.; Shaw, P.-C.; Wong, K.-B.; Uchiumi, T. Solution structure of human P1•P2 heterodimer provides insights into the role of eukaryotic stalk in recruiting the ribosome-inactivating protein trichosanthin to the ribosome. Nucleic Acids Res. 2013, 41, 8776–8787. [Google Scholar] [CrossRef] [PubMed]
- Grela, P.; Li, X.P.; Tchorzewski, M.; Tumer, N.E. Functional divergence between the two P1-P2 stalk dimers on the ribosome in their interaction with ricin A chain. Biochem. J. 2014, 460, 59–69. [Google Scholar] [CrossRef] [PubMed]
- Stechmann, B.; Bai, S.K.; Gobbo, E.; Lopez, R.; Merer, G.; Pinchard, S.; Panigai, L.; Tenza, D.; Raposo, G.; Beaumelle, B.; et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 2010, 141, 231–242. [Google Scholar] [CrossRef] [PubMed]
- Saenz, J.B.; Doggett, T.A.; Haslam, D.B. Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect. Immun. 2007, 75, 4552–4561. [Google Scholar] [CrossRef] [PubMed]
- Wahome, P.G.; Robertus, J.D.; Mantis, N.J. Small-molecule inhibitors of ricin and Shiga toxins. Curr. Top. Microbiol. Immunol. 2012, 357, 179–207. [Google Scholar] [PubMed]
- Yan, X.; Hollis, T.; Svinth, M.; Day, P.; Monzingo, A.F.; Milne, G.W.; Robertus, J.D. Structure-based identification of a ricin inhibitor. J. Mol. Biol. 1997, 266, 1043–1049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pruet, J.M.; Jasheway, K.R.; Manzano, L.A.; Bai, Y.; Anslyn, E.V.; Robertus, J.D. 7-substituted pterins provide a new direction for ricin A chain inhibitors. Eur. J. Med. Chem. 2011, 46, 3608–3615. [Google Scholar] [CrossRef] [PubMed]
- Saito, R.; Pruet, J.M.; Manzano, L.A.; Jasheway, K.; Monzingo, A.F.; Wiget, P.A.; Kamat, I.; Anslyn, E.V.; Robertus, J.D. Peptide-conjugated pterins as inhibitors of ricin toxin A. J. Med. Chem. 2013, 56, 320–329. [Google Scholar] [CrossRef] [PubMed]
- Endo, Y.; Mitsui, K.; Motizuki, M.; Tsurugi, K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J. Biol. Chem. 1987, 262, 5908–5912. [Google Scholar] [PubMed]
- Parikh, B.A.; Coetzer, C.; Tumer, N.E. Pokeweed antiviral protein regulates the stability of its own mRNA by a mechanism that requires depurination but can be separated from depurination of the α-sarcin/ricin loop of rRNA. J. Biol. Chem. 2002, 277, 41428–41437. [Google Scholar] [CrossRef] [PubMed]
- Baykal, U.; Tumer, N.E. The C-terminus of pokeweed antiviral protein has distinct roles in transport to the cytosol, ribosome depurination and cytotoxicity. Plant J. 2007, 49, 995–1007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yan, Q.; Li, X.P.; Tumer, N.E. N-glycosylation does not affect the catalytic activity of ricin A chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum. Traffic 2012, 13, 1508–1521. [Google Scholar] [CrossRef] [PubMed]
- Jetzt, A.E.; Cheng, J.S.; Tumer, N.E.; Cohick, W.S. Ricin A-chain requires c-Jun N-terminal kinase to induce apoptosis in nontransformed epithelial cells. Int. J. Biochem. Cell Biol. 2009, 41, 2503–2510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhabokritsky, A.; Mansouri, S.; Hudak, K.A. Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production. RNA 2014, 20, 1238–1247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Melchior, W.B.; Tolleson, W.H. A functional quantitative polymerase chain reaction assay for ricin, Shiga toxin, and related ribosome-inactivating proteins. Anal. Biochem. 2010, 396, 204–211. [Google Scholar] [CrossRef] [PubMed]
- Pierce, M.; Kahn, J.N.; Chiou, J.; Tumer, N.E. Development of a quantitative RT-PCR assay to examine the kinetics of ribosome depurination by ribosome inactivating proteins using Saccharomyces cerevisiae as a model. RNA 2011, 17, 201–210. [Google Scholar] [CrossRef] [PubMed]
- Zamboni, M.; Brigotti, M.; Rambelli, F.; Montanaro, L.; Sperti, S. High-pressure-liquid-chromatographic and fluorimetric methods for the determination of adenine released from ribosomes by ricin and gelonin. Biochem. J. 1989, 259, 639–643. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barbieri, L.; Brigotti, M.; Perocco, P.; Carnicelli, D.; Ciani, M.; Mercatali, L.; Stirpe, F. Ribosome-inactivating proteins depurinate poly(ADP-ribosyl)ated poly(ADP-ribose) polymerase and have transforming activity for 3T3 fibroblasts. FEBS Lett. 2003, 538, 178–182. [Google Scholar] [CrossRef] [Green Version]
- Barbieri, L.; Valbonesi, P.; Gorini, P.; Pession, A.; Stirpe, F. Polynucleotide: Adenosine glycosidase activity of saporin-l1: Effect on DNA, RNA and poly(A). Biochem. J. 1996, 319 Pt 2, 507–513. [Google Scholar] [CrossRef] [PubMed]
- Sperti, S.; Brigotti, M.; Zamboni, M.; Carnicelli, D.; Montanaro, L. Requirements for the inactivation of ribosomes by gelonin. Biochem. J. 1991, 277 Pt 1, 281–284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, X.-Y.; Link, T.M.; Schramm, V.L. Ricin A-chain: Kinetics, mechanism, and RNA stem−loop inhibitors. Biochemistry 1998, 37, 11605–11613. [Google Scholar] [CrossRef] [PubMed]
- Hines, H.B.; Brueggemann, E.E.; Hale, M.L. High-performance liquid chromatography-mass selective detection assay for adenine released from a synthetic RNA substrate by ricin A chain. Anal. Biochem. 2004, 330, 119–122. [Google Scholar] [CrossRef] [PubMed]
- Becher, F.; Duriez, E.; Volland, H.; Tabet, J.C.; Ezan, E. Detection of functional ricin by immunoaffinity and liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79, 659–665. [Google Scholar] [CrossRef] [PubMed]
- Heisler, I.; Keller, J.; Tauber, R.; Sutherland, M.; Fuchs, H. A colorimetric assay for the quantitation of free adenine applied to determine the enzymatic activity of ribosome-inactivating proteins. Anal. Biochem. 2002, 302, 114–122. [Google Scholar] [CrossRef] [PubMed]
- Sturm, M.B.; Schramm, V.L. Detecting ricin: Sensitive luminescent assay for ricin A-chain ribosome depurination kinetics. Anal. Chem. 2009, 81, 2847–2853. [Google Scholar] [CrossRef] [PubMed]
- Olsnes, S.; Pihl, A. Ricin—A potent inhibitor of protein synthesis. FEBS Lett. 1972, 20, 327–329. [Google Scholar] [CrossRef]
- Olsnes, S.; Fernandez-Puentes, C.; Carrasco, L.; Vazquez, D. Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur. J. Biochem. FEBS 1975, 60, 281–288. [Google Scholar] [CrossRef]
- Ready, M.P.; Kim, Y.; Robertus, J.D. Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action. Proteins 1991, 10, 270–278. [Google Scholar] [CrossRef] [PubMed]
- Sperti, S.; Montanaro, L.; Mattioli, A.; Stirpe, F. Inhibition by ricin of protein synthesis in vitro: 60S ribosomal subunit as the target of the toxin (short communication). Biochem. J. 1973, 136, 813–815. [Google Scholar] [CrossRef] [PubMed]
- Cawley, D.B.; Hedblom, M.L.; Houston, L.L. Protection and rescue of ribosomes from the action of ricin A chain. Biochemistry 1979, 18, 2648–2654. [Google Scholar] [CrossRef] [PubMed]
- Bai, Y.; Monzingo, A.F.; Robertus, J.D. The x-ray structure of ricin A chain with a novel inhibitor. Arch. Biochem. Biophys. 2009, 483, 23–28. [Google Scholar] [CrossRef] [PubMed]
- Wahome, P.G.; Bai, Y.; Neal, L.M.; Robertus, J.D.; Mantis, N.J. Identification of small-molecule inhibitors of ricin and Shiga toxin using a cell-based high-throughput screen. Toxicon 2010, 56, 313–323. [Google Scholar] [CrossRef] [PubMed]
- Bai, Y.; Watt, B.; Wahome, P.G.; Mantis, N.J.; Robertus, J.D. Identification of new classes of ricin toxin inhibitors by virtual screening. Toxicon 2010, 56, 526–534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, L.; Haslam, D.B. A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis. J. Med. Microbiol. 2005, 54, 1023–1030. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Redmann, V.; Oresic, K.; Tortorella, L.L.; Cook, J.P.; Lord, M.; Tortorella, D. Dislocation of ricin toxin A chains in human cells utilizes selective cellular factors. J. Biol. Chem. 2011, 286, 21231–21238. [Google Scholar] [CrossRef] [PubMed]
- Massey, S.; Quinones, B.; Teter, K. A cell-based fluorescent assay to detect the activity of Shiga toxin and other toxins that inhibit protein synthesis. Methods Mol. Biol. 2011, 739, 49–59. [Google Scholar] [PubMed]
- Cherubin, P.; Garcia, M.C.; Curtis, D.; Britt, C.B.; Craft, J.W., Jr.; Burress, H.; Berndt, C.; Reddy, S.; Guyette, J.; Zheng, T.; et al. Inhibition of cholera toxin and other AB toxins by polyphenolic compounds. PLoS ONE 2016, 11, e0166477. [Google Scholar] [CrossRef] [PubMed]
- Cherubin, P.; Quinones, B.; Teter, K. Cellular recovery from exposure to sub-optimal concentrations of AB toxins that inhibit protein synthesis. Sci. Rep. 2018, 8, 2494. [Google Scholar] [CrossRef] [PubMed]
- Ray, S.; Taylor, M.; Burlingame, M.; Tatulian, S.A.; Teter, K. Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids. PLoS ONE 2011, 6, e23692. [Google Scholar] [CrossRef] [PubMed]
- Pang, Y.-P.; Park, J.G.; Wang, S.; Vummenthala, A.; Mishra, R.K.; McLaughlin, J.E.; Di, R.; Kahn, J.N.; Tumer, N.E.; Janosi, L.; et al. Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach. PLoS ONE 2011, 6, e17883. [Google Scholar] [CrossRef] [PubMed]
- Manning, S.D.; Motiwala, A.S.; Springman, A.C.; Qi, W.; Lacher, D.W.; Ouellette, L.M.; Mladonicky, J.M.; Somsel, P.; Rudrik, J.T.; Dietrich, S.E.; et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA 2008, 105, 4868–4873. [Google Scholar] [CrossRef] [PubMed]
- Nataro, J.P.; Kaper, J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11, 142–201. [Google Scholar] [PubMed]
- Pickering, L.K.; Obrig, T.G.; Stapleton, B.F. Hemolytic-uremic syndrome and Enterohemorrhagic Escherichia coli. Pediatr. Infect. Dis. J. 1994, 13, 459–475. [Google Scholar] [CrossRef] [PubMed]
- Head, S.C.; Karmali, M.A.; Lingwood, C.A. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for b subunit modulation of a subunit function. J. Biol. Chem. 1991, 266, 3617–3621. [Google Scholar] [PubMed]
- Tesh, V.L.; Burris, J.A.; Owens, J.W.; Gordon, V.M.; Wadolkowski, E.A.; O’Brien, A.D.; Samuel, J.E. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 1993, 61, 3392–3402. [Google Scholar] [PubMed]
- Taylor, S.; Massiah, A.; Lomonossoff, G.; Roberts, L.M.; Lord, J.M.; Hartley, M. Correlation between the activities of five ribosome-inactivating proteins in depurination of tobacco ribosomes and inhibition of tobacco mosaic virus infection. Plant J. 1994, 5, 827–835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Harley, S.M.; Beevers, H. Ricin inhibition of in vitro protein synthesis by plant ribosomes. Proc. Natl. Acad. Sci. USA 1982, 79, 5935–5938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olsnes, S.; Refsnes, K.; Pihl, A. Mechanism of action of the toxic lectins abrin and ricin. Nature 1974, 249, 627–631. [Google Scholar] [CrossRef] [PubMed]
- Li, X.P.; Grela, P.; Krokowski, D.; Tchorzewski, M.; Tumer, N.E. Pentameric organization of the ribosomal stalk accelerates recruitment of ricin A chain to the ribosome for depurination. J. Biol. Chem. 2010, 285, 41463–41471. [Google Scholar] [CrossRef] [PubMed]
- Vance, D.J.; Mantis, N.J. Progress and challenges associated with the development of ricin toxin subunit vaccines. Expert Rev. Vaccines 2016, 15, 1213–1222. [Google Scholar] [CrossRef] [PubMed]
- O’Hara, J.M.; Yermakova, A.; Mantis, N.J. Immunity to ricin: Fundamental insights into toxin-antibody interactions. Curr. Top. Microbiol. Immunol. 2012, 357, 209–241. [Google Scholar] [PubMed]
- Wahome, P.G.; Mantis, N.J. High-throughput, cell-based screens to identify small-molecule inhibitors of ricin toxin and related category B ribosome inactivating proteins (RIPs). Curr. Prot. Toxicol. 2013. [Google Scholar] [CrossRef]
- Alewine, C.; Hassan, R.; Pastan, I. Advances in anticancer immunotoxin therapy. Oncologist 2015, 20, 176–185. [Google Scholar] [CrossRef] [PubMed]
- Grela, P.; Li, X.P.; Horbowicz, P.; Dzwierzynska, M.; Tchorzewski, M.; Tumer, N.E. Human ribosomal P1-P2 heterodimer represents an optimal docking site for ricin A chain with a prominent role for P1 C-terminus. Sci. Rep. 2017, 7, 5608. [Google Scholar] [CrossRef] [PubMed]
- Tesh, V.L. The induction of apoptosis by Shiga toxins and ricin. Curr. Top. Microbiol. Immunol. 2012, 357, 137–178. [Google Scholar] [PubMed]
Method Name | Assay System | RTA Sensitivity (Substrate) * | Detection Method | Advantages | Disadvantages | References |
---|---|---|---|---|---|---|
Aniline cleavage | In vitro | Rib: 1 ng rRNA: 10 ng | Polyacrylamide gel separation. | First depurination method. Demonstrated mechanism of action of RIPs. | Labor intensive. Susceptible to RNase contamination. Not adaptable for HTS. | [9,11,16,49] |
Primer extension | In vitro In vivo | Rib: 10 ng | Polyacrylamide gel separation. Quantification by PhosphorImager. | More accurate quantification with dual primer. Allows localization of the depurination site. | Labor intensive. Susceptible to RNase contamination. Uses radioactive labeling. Not adaptable to HTS. Requires knowledge of the depurination site for primer design. | [20,38,50,53] |
qRT-PCR | In vitro In vivo | Rib: 0.18 ng rRNA: 180 ng | qRT-PCR with either absolute quantification or relative quantification by calculating fold change compared to a control. | Highly sensitive. Accurate quantification. Does not require radioactive material. | Requires knowledge of the site of depurination for primer design. | [34,56] |
HPLC | In vitro | SRL: 100ng | Adenine derivatization followed by HPLC or direct adenine detection by HPLC-MS. | Highly sensitive. Allows calculation of enzymatic kinetics. Does not require radioactive material. | Labor intensive and time consuming. Not applicable to in vivo studies. Expensive equipment. Not adaptable to HTS. | [57,61,62] |
Enzyme-coupled adenine detection | In vitro | Rib: 1.5 ng SRL: 60 ng | Adenine conversion into readable colorimetric shift signal or luciferase light signal quantified by a microplate reader. | Fast and highly sensitive. Allows continuous measurement of depurination. Does not require radioactive material. Adaptable to HTS. | High background if ingredients not pure. APRTase, PPDK and PRPP can be hard to obtain. Small molecules may interfere with enzymes in inhibitor screens. Saturating ribosome concentrations are hard to obtain. Not applicable to in vivo studies. | [34,36,64,65] |
Method Name | Advantages | Disadvantages | References | |
---|---|---|---|---|
In vitro assays | Radioactive amino acid incorporation | First assay available for RIP activity. | Requires handling of radioactive materials. | [66,67,68,69] |
Luciferase synthesis | Adaptable to HTS. No radioactive materials. | Luciferase can be subject to interference by small inhibitor molecules leading to false positives. | [71,73,80] | |
Mammalian cell-based assays | In-cell radioactive amino acid incorporation | Adaptable to HTS. | Requires handling of radioactive materials. | [43] |
In-cell luciferase synthesis | Adaptable to HTS. No radioactive materials. | Requires transfection of cells. Low sensitivity, high background and high sample-to-sample variation. | [44,74] | |
Cell-based luciferase assay | Adaptable to HTS. No radioactive materials. No cell transfection. | Can yield nonspecific inhibitors. | [72] | |
In-cell GFP synthesis | Highly sensitive. Easy detection of GFP. | Requires cell transfection. | [39,40,75] |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhou, Y.; Li, X.-P.; Kahn, J.N.; Tumer, N.E. Functional Assays for Measuring the Catalytic Activity of Ribosome Inactivating Proteins. Toxins 2018, 10, 240. https://doi.org/10.3390/toxins10060240
Zhou Y, Li X-P, Kahn JN, Tumer NE. Functional Assays for Measuring the Catalytic Activity of Ribosome Inactivating Proteins. Toxins. 2018; 10(6):240. https://doi.org/10.3390/toxins10060240
Chicago/Turabian StyleZhou, Yijun, Xiao-Ping Li, Jennifer N. Kahn, and Nilgun E. Tumer. 2018. "Functional Assays for Measuring the Catalytic Activity of Ribosome Inactivating Proteins" Toxins 10, no. 6: 240. https://doi.org/10.3390/toxins10060240
APA StyleZhou, Y., Li, X. -P., Kahn, J. N., & Tumer, N. E. (2018). Functional Assays for Measuring the Catalytic Activity of Ribosome Inactivating Proteins. Toxins, 10(6), 240. https://doi.org/10.3390/toxins10060240